Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danielle Fisher

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Psycho-Oncology|August 26, 2010
The link between value motives, value success, and well-being among people diagnosed with cancerJoseph Ciarrochi, Danielle Fisher, Lisbeth Lane
Delaware Journal of Public Health|April 7, 2026
How Strong Data Infrastructure Could Transform Delaware's Firearm Violence Prevention EcosystemLauren Footman, Danielle Fisher, Alexandra Wynn
Cephalalgia : an International Journal of Headache|October 13, 2010
Cerebrospinal fluid phospholipase C activity increases in migraineAlfred N Fonteh, Rainbow Chung, Tara L Sharma, et al.
Eclinicalmedicine|July 29, 2025
Safety and immunogenicity of UB-612 heterologous booster in adults primed with mRNA, adenovirus, or inactivated COVID-19 vaccines: a randomized, active-controlled, Phase 3 trialAlexander Rumyantsev, Lixia Wang, Shixia Wang, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Psycho-Oncology|August 26, 2010
The link between value motives, value success, and well-being among people diagnosed with cancerJoseph Ciarrochi, Danielle Fisher, Lisbeth Lane
Delaware Journal of Public Health|April 7, 2026
How Strong Data Infrastructure Could Transform Delaware's Firearm Violence Prevention EcosystemLauren Footman, Danielle Fisher, Alexandra Wynn
Cephalalgia : an International Journal of Headache|October 13, 2010
Cerebrospinal fluid phospholipase C activity increases in migraineAlfred N Fonteh, Rainbow Chung, Tara L Sharma, et al.
Eclinicalmedicine|July 29, 2025
Safety and immunogenicity of UB-612 heterologous booster in adults primed with mRNA, adenovirus, or inactivated COVID-19 vaccines: a randomized, active-controlled, Phase 3 trialAlexander Rumyantsev, Lixia Wang, Shixia Wang, et al.
Pageof 1